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Chemical biology: the promise, and confusion, of adolescence 
William Wells 
It takes time for any new scientific discipline to gain 
momentum, and chemical biology is no exception. But 
with the formation of new training programs and 
interdisciplinary departments, the changes are coming. 
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In the beginning there was biochemistry. Its practitioners 
were well versed in the ways of molecules, and respectful of 
chemists. But then came the scourge of molecular biology. 
After several decades of ascendancy, molecular biology is 
facing an increasingly powerful challenger in the form of 
chemical biology. “Molecular biology is so seductive and 
has taken over so much of biology; it has permeated all the 
way down to high schools,” says Ron Estabrook of the 
University of Texas Southwestern Medical Center 
(UTSW; Dallas). “We want to get away from the descrip- 
tiveness of biology to the quantitation of chemistry. We 
want to bring back a type of thinking that molecular 
biology doesn’t encompass.” 
For UTSW that effort involves creating a Chemical 
Biology graduate training program, and hiring more 
chemists and chemical biologists. Both changes were 
requested by Steven McKnight as conditions for accepting 
the chairmanship of the UTSW Biochemistry Depart- 
ment. McKnight says he is intent on building a depart- 
ment that is equally strong in biophysics, molecular 
biology, and chemistry. 
UTSW is far from the only research center making moves 
towards chemical biology. Departments are changing 
names, forming graduate programs, and hiring new 
faculty. In many cases faculty are trying to create what 
they never had-a truly interdisciplinary training-and 
thus bootstrap a young field into prominence. “Five years 
from now,” says McKnight, “a biochemistry department 
that doesn’t have chemistry in it I think is going to be a 
weak department.” 
Chemical biology: many things to many people 
If chemistry used to be integral to a biochemistry depart- 
ment, it rarely is today. “To be brutally honest, there are 
very few departments that are old-school biochemistry 
departments,” says Gerald Koudelka of the State University 
of New York (SUNY) at Buffalo. “Many of them are very far 
away from what I would consider a biochemistry depart- 
ment.” McKnight sees his changes as an embrace of the 
past. “This is nothing fancy,” he says. “I think this is getting 
back to the roots.” 
But for others chemical biology is not just the return of 
enzyme purification and intermediary metabolism, so 
what is it? “Everybody’s definition will be different,” says 
Estabrook. “The first thing is a rigor of thinking that takes 
into account the key role of functional groups, and the key 
role of quantitation.” For other researchers, the focus is 
the use of small molecule inhibitors that can be titrated in 
and out at will, and used to study processes such as angio- 
genesis that are hard to address using genetics. “Chemical 
biology is not a totally novel creation, but the emphasis on 
synthesis is what sets it apart, especially complex synthe- 
sis,” says Tom Scanlan of the University of California, San 
Francisco (UCSF). Notably these chemical tools can be 
used to study an entire pathway, or even multiple path- 
ways, rather than taking the traditional approach of focus- 
ing on a single protein. 
The name game 
In adopting these tools, more chemists have moved 
towards biology than biologists towards chemistry. Thus 
the ultimate embrace of chemical biology-the addition 
of ‘chemical biology’ to a department’s name-has come 
from chemistry departments such as those at Harvard (in 
1995) and Cornell (ongoing). The Scripps Research Insti- 
tute in La Jolla, California, created a new Skaggs Institute 
of Chemical Biology in 1996, which continues a commit- 
ment dating back at least to 1991, when the institute’s 
director, Richard Lerner, hoped that Scripps would be 
seen as “the Bell Labs of chemical biology.” 
Changing a name is not always the best or simplest solution, 
however. In the University of California (UC) system, for 
example, Scanlan says a name change requires UC regents’ 
approval, and funding approval by the state legislature. 
And then there is the issue of territory. “Molecular biology 
can play within a biology department. Chemical biology 
has to play in between,” says Gerald Joyce of Scripps. 
“Scripps is all mixed together, so there’s no threat.” Like 
Scripps, UCSF is crowded into one or a few clustered 
buildings, so department naming is less of an issue. As 
UCSF plans its move to reclaimed land near the San Fran- 
cisco bay, it is rearranging itself into ‘affinity’ groups, one 
of which is chemical biology. These groups will be assem- 
bled without regard to departmental affiliation. 
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Departments still control hiring decisions, but at the Uni- 
versity of Wisconsin at Madison even that process has 
been distributed. Laura Kiessling of the chemistry 
department explains that “we haven’t switched the 
department name more because we don’t want all of 
[chemical biology] to be localized in chemistry.” Instead, 
Kiessling and fellow faculty member Jo Handelsman put 
together one of several interdisciplinary hiring programs 
at the university. The chemical biology faculty hired 
under the Kiessling/Handelsman proposal take up 
appointments in any one of a number of departments, 
including biochemistry and chemical engineering. “At 
Madison it’s not coming solely from the chemists, it’s 
coming from a campus-wide initiative,” says Kiessling. 
“That to me is exciting, because it suggests that other 
disciplines are recognizing how important an understand- 
ing of chemistry can be.” 
Bringing in new talent 
In the chemical biology hiring drives at several universi- 
ties, the criteria for a good chemical biologist are about as 
clear as the definition of chemical biology. For UCSF’s 
Scanlan, chemistry comes first. “I look to see that they 
[the job applicants] are truly chemists-which means a 
Ph.D. in a chemistry department-and then they are 
expected to get up to speed in biology in a postdoc,” he 
says. “Usually we have to make a judgement call on the 
potential rather than the publication record in biology.” 
“I personally like to see that they can synthesize mol- 
ecules, because I think that is where the good things are 
coming from,” he says. “When people are creating new 
ligands and inhibitors, interesting things happen.” 
The desire to build a chemical biology group is not 
enough if the qualified applicants are not out there. 
“Without question there’s a shortage,” says Scanlan. “We 
see that when we’re hiring. It’s very difficult to get the 
right person.” 
In Europe there are other challenges. According to Don 
Hilvert, who recently moved from Scripps to the Federal 
Institute of Technology (ETH) in Zurich, Switzerland, 
the typical German university has only one or two organic 
chemistry professors, who are expected to operate in the 
mainstream of organic synthesis. “Chemical biology is less 
well developed in Europe than in the US, with perhaps 
the exception of England, but that’s changing,” says 
Hilvert. At the ETH, he says, there is greater latitude for 
explorations in chemical biology. And in France chemical 
biology is receiving a lift with the establishment of the 
European Institute of Chemistry and Biology (IECB) in 
Pessac near Bordeaux. The IECB will eventually house 
up to 200 working scientists, with a large effort in struc- 
tural biology and biophysics, and other groups focused on 
natural product and combinatorial library synthesis. 
Training the ground troops 
One obvious solution to the shortage of chemical biology 
faculty candidates is education. In such a young field, it is 
not surprising that education mechanisms are only now 
falling into place. The first crop of chemical biologists 
have seized upon any available help to get a grasp of two 
very different fields. “There’s a lot of self-education going 
on, and that’s why a more formal training would really 
accelerate the process,” says Craig Crews (Yale University, 
New Haven, Connecticut). 
Training grants from the National Institutes of Health 
(NIH) have encouraged the growth of interdisciplinary 
graduate programs, with chemical biology being a signifi- 
cant beneficiary. Newly formed programs include those at 
Duke (started in 1994), Philadelphia State University in 
Pennsylvania (started in 1996), UTSW (started in 1997), 
and UCSF and SUNY, Buffalo (both starting in 2000). 
Generally, training programs are not affiliated with any 
single department, so the territorial issues encountered in 
faculty hiring are moot. Recruiting students is a mixed 
bag: Estabrook at UTSW says that biology students are 
reluctant to do chemistry, so it will be important to spread 
the gospel in undergraduate courses, but Matthew Shair of 
Harvard University (Cambridge, Massachusetts) says 
there is no such problem in chemistry departments. 
“There is a higher proportion [of chemistry graduate stu- 
dents] every year interested in the chemical biology 
aspects,” he says. “People are coming in saying, ‘I want to 
learn about making molecules, but then I want to do 
something interesting with those molecules’.” 
The distinguishing characteristics of the chemical biology 
programs vary, with some programs incorporating little 
more than a required biology course with a chemistry 
degree. Others add custom-designed courses, seminar 
series, and the requirement for laboratory rotations in both 
sponsoring departments. 
Exactly what works best is not yet clear. “I think the rules 
are still being written,” says Shair. “But you need real 
interdisciplinary training. That doesn’t mean being 
trained in biology in a vacuum and then being trained in 
chemistry in a vacuum. It’s a different type of research.” 
Shair is, for example, developing a course to address the 
emerging field of diversity synthesis-making large 
libraries of complex and diverse chemicals. 
Chemical biology students may have to take more courses 
in the early years of their degrees, but compensation 
should come in the form of jobs in both academia and, 
especially, industry. Biotechnology companies have been 
steadily moving away from gene research and protein 
therapeutics and into chemistry and small molecule 
drugs. That change is in turn influencing academia, espe- 
cially at UTSW. “During my five years at [the biotech 
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company] Tularik I got used to working with chemists, 
and just loved it,” says McKnight. “Being in a biochem- 
istry department without chemists there was something 
critical missing.” 
Research interests in academia and industry are likely to 
remain distinct, however, as industry is focused on drugs, 
whereas academics are worried more about testing 
hypotheses, often using chemicals that are clearly 
unsuited for use as medications, and on time-scales that 
are financially untenable in industry. 
Motivations and opportunities 
Any new field needs money, and chemical biology has 
benefited from the emphasis of funding bodies on inter- 
disciplinary research. Grants for chemical approaches to 
cancer research from the National Cancer Institute have 
helped fund the Institute of Chemistry and Cell Biology 
(ICCB) at Harvard Medical School (Boston, Massachu- 
setts), the Combinatorial Chemistry Center at the Univer- 
sity of Pittsburgh, and programs at Scripps and the Torrey 
Pines Research Institute (La Jolla, California). Standard 
funding sources are also adapting to chemical biology. 
“There are no new [NIH] study sections for chemical 
biology,” says Joyce, “but people are willing to take in a 
little more hard-core chemistry with their biology.” 
Successes with natural products, such as the use of lepto- 
mycin to isolate a nuclear export receptor and of capsaicin 
to isolate a pain receptor, have raised the profile of chemi- 
cal biology. But the science that is driving the expansion 
of chemical biology perhaps most directly is combinatorial 
chemistry, which provides access to a vast supply of novel 
chemicals. Making sure that those chemicals are diverse 
enough and large enough to be biologically interesting is 
one of the challenges for chemists. “From target-oriented 
synthesis to diversity-oriented synthesis there isn’t always 
a smooth connection - the reactions have to be exquis- 
itely general,” says Shair. “It’s a fantastic opportunity for 
organic synthesis development.” 
But the chemical challenge discourages some. “It’s one 
thing to be able to make a lOO,OOO-compound library; it’s 
another thing to get it to be useful for biological 
research,” says Leroy Hood, the Chairman of the Depart- 
ment of Molecular Biotechnology at the University of 
Washington, Seattle. Hood’s department is combining 
biology and engineering to focus on genomics and pro- 
teomics; a similar fusion of interests is planned for a new 
Molecular Engineering building at the University of Cali- 
fornia at Berkeley. Hood is also involved with a new Insti- 
tute for Quantitative Systems Biology at Seattle, which 
will address the behavior of complex biological systems. 
Initially he will observe how these systems react to 
genetic perturbations, but eventually he hopes to hopes to 
use chemicals as probes. “Combinatorial chemistry,” he 
says, “is a powerful way to give us shapes to interrogate 
the biology.” 
The difficulties are acknowledged by the chemists. “Mol- 
ecular biology was accessible to everyone,” says Shair. 
“Chemical biology is not as accessible; the reagents are 
not accessible. The chemistry is still very hard, whereas 
making mutants is not so hard. There is still a lot to be 
worked out.” Shair hopes that a few centers will be able to 
generalize the process, so that it can be exported to less 
chemically oriented centers such as those in Seattle and 
Berkeley. The initial work may come from those with an 
abundance of both chemistry and money, such as 
Harvard’s ICCB and its sister institution the Harvard 
Center for Genomics and Proteomics (CGP), and the new 
Novartis Institute for Functional Genomics (La Jolla, Cali- 
fornia). The Novartis institute is directed by Peter Schultz 
and has been funded by Novartis (Basel, Switzerland) to 
the tune of US$250 million. 
Once the export process is under way, genomics may be 
the field that needs chemical biology the most. “I think 
chemical biology plays right into genomics,” says Joyce. 
“With genomics you identify genes, but ultimately you 
have to tweak them and turn them on and off.” Figuring 
out what all those genes are doing will take a lot of work, 
but some clever chemistry will make the process go a 
whole lot faster. 
